ZIKAction brings together clinicians and researchers in Central and South America, the Caribbean and Europe with expertise in maternal and child health, infectious disease epidemiology, virology, immunology, and pathology with the goal of addressing the ZIKV outbreak and preparing for eventual other regional emerging infectious disease outbreaks.
Led by the PENTA Foundation, the ZIKAction research consortium has the complementary goals of:
1) developing a multidisciplinary multinational ready-to-act network capable of rapidly addressing any maternal and paediatric research need arising from (re-)emerging infectious diseases including Zika virus and
2) conducting an interdisciplinary programme of research studies within this network to address key knowledge gaps relating to ZIKV epidemiology, natural history and pathogenesis, with a particular emphasis on maternal and child health.
ZIKAction has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 734857.